Replies to post #106103 on Biotech Values

[HattieTheWitch]

The Street thinks Teva has its best scientists working on t-enox. If that is not the case, a 2nd generic approval would be perceived as less likely to occur.

MUCH less likely, I imagine.

When you said "buyers of MNTA" - did you mean possible acquirers, or shorts?

Thank you.